全文获取类型
收费全文 | 15768篇 |
免费 | 735篇 |
国内免费 | 378篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 144篇 |
妇产科学 | 296篇 |
基础医学 | 1950篇 |
口腔科学 | 245篇 |
临床医学 | 1035篇 |
内科学 | 2101篇 |
皮肤病学 | 214篇 |
神经病学 | 853篇 |
特种医学 | 264篇 |
外国民族医学 | 6篇 |
外科学 | 769篇 |
综合类 | 2384篇 |
现状与发展 | 1篇 |
预防医学 | 756篇 |
眼科学 | 227篇 |
药学 | 3498篇 |
6篇 | |
中国医学 | 1331篇 |
肿瘤学 | 765篇 |
出版年
2023年 | 202篇 |
2022年 | 316篇 |
2021年 | 563篇 |
2020年 | 635篇 |
2019年 | 453篇 |
2018年 | 390篇 |
2017年 | 624篇 |
2016年 | 639篇 |
2015年 | 576篇 |
2014年 | 1400篇 |
2013年 | 2126篇 |
2012年 | 1783篇 |
2011年 | 1574篇 |
2010年 | 1156篇 |
2009年 | 946篇 |
2008年 | 792篇 |
2007年 | 406篇 |
2006年 | 364篇 |
2005年 | 343篇 |
2004年 | 266篇 |
2003年 | 182篇 |
2002年 | 134篇 |
2001年 | 56篇 |
2000年 | 37篇 |
1999年 | 26篇 |
1998年 | 46篇 |
1997年 | 39篇 |
1996年 | 36篇 |
1995年 | 28篇 |
1994年 | 15篇 |
1993年 | 14篇 |
1992年 | 9篇 |
1990年 | 17篇 |
1989年 | 11篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 64篇 |
1984年 | 77篇 |
1983年 | 87篇 |
1982年 | 85篇 |
1981年 | 55篇 |
1980年 | 58篇 |
1979年 | 42篇 |
1978年 | 36篇 |
1977年 | 28篇 |
1976年 | 23篇 |
1975年 | 24篇 |
1974年 | 20篇 |
1973年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
991.
Tu Z Han X Wang X Hou Y Shao B Wang X Zhou Q Fan Q 《Clinica chimica acta; international journal of clinical chemistry》2003,333(1):85-90
BACKGROUND: The cardiovascular protective mixture (CVPM) is a concoction of nine Chinese traditional medicines: Dan-shen root, Szechwan lovge rhizome, Chinese angelica, Hawthorn fruit, Safflower, Peach seed, Red peony root, earthworm, and membranous milkvetch root. These medicines are used to cure cardiovascular disease in China. METHODS: Animal models were established by feeding the Sprague-Dawley (SD) rats with lipid-rich forage. Serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) were measured. Malondialdehyde (MDA) content was determined to monitor lipid peroxidation. The 6-keto-prostaglandin F(1alpha)(6-keto-PGF(1alpha)) concentration was measured by radioimmunoassay to investigate the content of prostacyclin (PGI(2)). Electron microscope (JEM-1200EX) was used to observe the microstructure of the vascular endothelium. Rat aortic endothelial cell was cultured to investigate the effect of CVPM on vascular endothelial cell in vitro. RESULTS: CVPM inhibited the accumulation of TC, LDL-C, and MDA in vivo, when the rats were fed with cholesterol diet. CVPM promoted synthesizing and excreting of PGI(2), since it is capable of activating the proliferation of vascular endothelium in vitro. Electron micrographs showed that CVPM had notable protective effect on the vascular endothelium and prevented the shedding of these cells from subendothelial layer. CONCLUSIONS: CVPM could ameliorate the internal environment in which vascular endothelial cells lived, and activate the proliferation of these cells. Through these mechanisms, CVPM protect vascular endothelial cell from being harmed by excess cholesterol in vivo. 相似文献
992.
目的探讨在多器官功能衰竭综合征(MODS)患者中细胞因子TNF-α和血管内皮细胞功能标志物的变化。方法动态观察MODS及非MODS患者一氧化氮(NO)、内皮素(ET-1)、组织纤溶酶原激活物(t-Pa)、纤溶酶原激活物抑制物-1(PAI-1)、循环内皮细胞(CEC)、肿瘤坏死因子(TNF-α)的浓度,同时给予Marshall评分。结果与非MODS组相比,MODS组、死亡组的TNF-α、ET- 1、PAI-1、CEC、Marshall评分显著升高(P<0.05),而NO、t-Pa显著降低(P<0.05)。结论TNF-α作为炎性因子在MODS的进展中起重要作用;在MODS时内皮细胞的损伤表现为ET-1、PAI-1、CEC增加,NO、t-PA减少,Marshall评分对于危重症患者的评估是敏感指标。 相似文献
993.
目的检测白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)在急性脑梗死患者血清中的表达并分析其临床意义。方法2015年5月至2017年8月,选取100例急性脑梗死患者、100例健康体检者,分别设为观察组、对照组。观察组依据病情轻重、病灶大小分为重、中、轻度组,大、中、小灶组。对比组间IL-6、TNF-α、CRP表达情况。结果观察组血清IL-6、TNF-α、CRP水平明显高于对照组(P<0.05)。不同病情、病灶组间的血清IL-6、TNF-α、CRP水平比较,差异有统计学意义(P<0.05)。血清IL-6、TNF-α水平:重度组>中度组>轻度组(P<0.05);血清CRP水平:重度组>中、轻度组(P<0.05)。血清IL-6、CRP水平:大灶组>中灶组>小灶组(P<0.05);血清TNF-α水平:大灶组>中、小灶组(P<0.05)。结论IL-6、TNF-α、CRP在急性脑梗死患者血清中高表达,可能参与疾病的发生发展,临床应给予重视。 相似文献
994.
目的 探讨核转录因子-κB(NF-κB)及肿瘤坏死因子-α(TNF-α)在大鼠肺血管内巨噬细胞(PIM)内的表达及吡咯醛二硫氨基甲酸(PDTC)对其表达的影响.方法 SD大鼠随机分4组:对照组、PDTC对照组、CCI4组、CCI4+PDTC组.取动脉血作血气分析,静脉血测内毒素和肝功能.取肠系膜淋巴结作细菌培养.应用免疫组化方法 观察PIM的粘附、聚集情况,以及TNF-α和NF-κB的蛋白表达和定位.非放射性凝胶电泳阻滞实验(EMSA)检测NF-κB活性,SYBR Green I实时定量PCR方法 检测肺组织中TNF-α的mRNA表达.结果 CCl4组发展成肝肺综合征(HPS)模型,表现为PaO2、PaCO2降低和肺泡一动脉血氧分压(A-aDO2)升高,肝功能异常,内毒素血症.CCl4组肠系膜淋巴结培养阳性率为62.5%(5/8),与CCl4+PDTC组的66.7%(6/9)比较差异无统计学意义(P>0.05).CCl4组超过10个巨噬细胞的血管为60.8%(292/480),而CCl4+PDTC组仅为19.6%(106/540),两组比较差异有统计学意义(P<0.01).对照组和PDTC对照组中肺血管内无巨噬细胞聚集.免疫组化染色NF-κB和TNF-α蛋白均在CCl4组的PIM中表达.CCl4组的NF-κB活性和TNF-α的mRNA表达明显高于对照组、PDTC对照组和CCl4+PDTC组(均P<0.05).结论 NF-κB诱导PIM内TNF-α表达在HPS中发挥重要作用,PDTC通过抑制PIM中NF-κB的活性,降低PIM活性以及其中TNF-α表达,从而改善HPS. 相似文献
995.
996.
Hongzhong Wu Xin Liang Yishi Fang Xiaoran Qin Yuanxing Zhang Jianwen Liu 《Biomedicine & Pharmacotherapy》2008
Resveratrol has been shown recently to exhibit antimetastatic effect on various human solid tumors. However, the possible molecular mechanism for its antimetastatic action needs to be elucidated. In this study, we investigated the effect of resveratrol on metastasis potential of colon carcinoma cells under normoxia and hypoxia in vitro. These results showed that, resveratrol can restrict the migration, adhesion, invasion and MMP-9 and MMP-2 secretion in Lovo cells cultured under normoxia and hypoxia. Hypoxia and iron chelator 2,2′-dipyridyl treatment can stimulate the invasion and migration enhancement of Lovo cells, while resveratrol exhibited substantial resistance on the metastasis potential stimulation by inhibiting the mRNA expression of VEGF and MMP-9 in colon carcinoma cells under normoxia and hypoxia, reducing HIF-1α protein expression under hypoxia. Also, iron chelator 2,2′-dipyridyl treatment showed approximately the same effect on metastasis potential as Lovo cells cultured under hypoxia. These data demonstrated that, the antimetastatic effect of resveratrol under hypoxia were associated with the restriction of HIF-1α protein expression and stabilization, which could be a promising drug target for resveratrol in the development of an effective chemopreventive and anticancer therapy in human tumors. 相似文献
997.
Wen-Yi Tseng Yeong-Jian Jan Wu Tai-Yun Yang Nien-Yi Chiang Wen-Pin Tsai Siamon Gordon Gin-Wen Chang Chang-Fu Kuo Shue-Fen Luo Hsi-Hsien Lin 《Journal of microbiology, immunology, and infection》2018,51(4):485-491
Background
GPR56/ADGRG1 is a member of the adhesion-class G protein-coupled receptor (aGPCR) family important in brain development, oncogenesis and tumor metastasis. Like other aGPCRs, GPR56 is cleaved at the GPCR proteolysis site (GPS) motif into an N-terminal fragment (NTF) and a C-terminal fragment (CTF). Existence of soluble GPR56 (sGPR56) has been shown in vitro, however the underlying mechanism and its pathophysiologic role remains undetermined.Objective
To assess the presence of sGPR56 in human serum using ELISA assay and compare the serum sGPR56 levels among patients of various chronic inflammatory diseases and healthy subjects.Patients and methods
In this study, serum samples from patients with systemic lupus erythematosus (SLE) (n = 57), rheumatoid arthritis (RA) (n = 95), Sjögren's syndrome (SS) (n = 29), ankylosing spondylitis (AS) (n = 51), and normal controls (n = 81) were analyzed using sGPR56-specific ELISA.Result
We show that serum sGPR56 levels are increased in patients of RA, but not in those with SLE, SS and AS. Intriguingly, serum sGPR56 levels in RA patients correlated with positive rheumatoid factor, a marker of bone erosion and poor outcome. In addition, an elevated sGPR56 level is also noted in RA patients with higher tumor necrosis factor level.Conclusion
we conclude that sGPR56 is present in vivo and sGPR56 level is elevated in certain chronic inflammatory diseases such as RA. Hence, sGPR56 might be considered a potential biomarker for RA disease progression. 相似文献998.
Desirée Schubert Marie-Christine Klein Sarah Hassdenteufel Andrés Caballero-Oteyza Linlin Yang Michele Proietti Alla Bulashevska Janine Kemming Johannes Kühn Sandra Winzer Stephan Rusch Manfred Fliegauf Alejandro A. Schäffer Stefan Pfeffer Roger Geiger Adolfo Cavalié Hongzhi Cao Fang Yang Bodo Grimbacher 《The Journal of allergy and clinical immunology》2018,141(4):1427-1438
999.
Benjamin F. Sallis Lena Erkert Sherezade Moñino-Romero Utkucan Acar Rina Wu Liza Konnikova Willem S. Lexmond Matthew J. Hamilton W. Augustine Dunn Zsolt Szepfalusi Jon A. Vanderhoof Scott B. Snapper Jerrold R. Turner Jeffrey D. Goldsmith Lisa A. Spencer Samuel Nurko Edda Fiebiger 《The Journal of allergy and clinical immunology》2018,141(4):1354-1364.e9
1000.